Voloridge Investment Management
IART icon

Voloridge Investment Management’s Integra LifeSciences IART Stock Holding History

Voloridge Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Sell
252,904
-180,484
-42% -$1.98M 0.01% 803
2025
Q4 		$5.38M Sell
433,388
-60,570
-12% -$805K 0.02% 748
2025
Q3 		$7.08M Sell
493,958
-255,830
-34% -$3.5M 0.02% 641
2025
Q2 		$9.2M Buy
749,788
+165,219
+28% +$2.4M 0.03% 570
2025
Q1 		$12.9M Sell
584,569
-144,847
-20% -$3.41M 0.05% 488
2024
Q4 		$16.5M Sell
729,416
-329,710
-31% -$7.2M 0.06% 409
2024
Q3 		$19.2M Buy
1,059,126
+231,270
+28% +$5.36M 0.07% 385
2024
Q2 		$24.1M Buy
827,856
+256,536
+45% +$7.61M 0.09% 309
2024
Q1 		$20.3M Buy
571,320
+260,992
+84% +$10.4M 0.07% 332
2023
Q4 		$13.5M Buy
310,328
+33,935
+12% +$1.34M 0.05% 403
2023
Q3 		$10.6M Buy
276,393
+8,488
+3% +$357K 0.05% 453
2023
Q2 		$11M Buy
267,905
+168,751
+170% +$8.12M 0.05% 435
2023
Q1 		$5.69M Sell
99,154
-53,835
-35% -$3.03M 0.03% 634
2022
Q4 		$8.58M Sell
152,989
-66,807
-30% -$3.4M 0.05% 472
2022
Q3 		$9.31M Buy
219,796
+86,663
+65% +$4.44M 0.05% 462
2022
Q2 		$7.19M Buy
133,133
+42,045
+46% +$2.53M 0.04% 549
2022
Q1 		$5.85M Buy
+91,088
New +$6M 0.03% 588
2021
Q2 		– Sell
-3,677
Closed -$254K – 1684
2021
Q1 		$254K Sell
3,677
-81,981
-96% -$5.55M ﹤0.01% 1278
2020
Q4 		$5.56M Sell
85,658
-39,201
-31% -$2.11M 0.05% 427
2020
Q3 		$5.9M Buy
124,859
+105,714
+552% +$5.03M 0.05% 405
2020
Q2 		$900K Sell
19,145
-15,429
-45% -$758K 0.01% 887
2020
Q1 		$1.54M Sell
34,574
-3,913
-10% -$205K 0.04% 416
2019
Q4 		$2.24M Buy
+38,487
New +$2.29M 0.04% 466

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Voloridge Investment Management's IART Position: Q1 2026 in Review

Voloridge Investment Management reduced its Integra LifeSciences (IART) stake by 42% in Q1 2026, selling an estimated $1.98M and leaving 252,904 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #803.

Voloridge Investment Management first reported a position in IART in Q4 2019 and has held it in 23 quarters since. The position peaked at $24.1M in Q2 2024. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Voloridge Investment Management held 252,904 shares of Integra LifeSciences worth $2.38M as of Q1 2026.
  • Voloridge Investment Management sold 180,484 Integra LifeSciences shares in Q1 2026, an estimated $1.98M.
  • Integra LifeSciences made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #803 holding.
  • Voloridge Investment Management first reported a position in Integra LifeSciences in Q4 2019 and has held it in 23 quarters since.
  • Voloridge Investment Management's Integra LifeSciences position peaked at $24.1M in Q2 2024.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.